產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
產(chǎn)品概述
名稱 | CT26.WT (小鼠結(jié)腸癌細胞) (STR鑒定正確) |
別稱 | CT26WT |
種屬 | 小鼠 |
生長特性 | 貼壁細胞 |
細胞形態(tài) | 成纖維細胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:3-1:4 |
推薦換液頻率 | 2-3次/周 |
背景描述 | CT26細胞是以N-亞硝基-N-甲基氨基甲酸酯(NNMU)誘導(dǎo)形成的未分化結(jié)腸癌細胞株,它克隆形成的細胞株命名為CT26.WT。用包含編碼典型腫瘤相關(guān)抗原(TAA)β-半乳糖苷酶(β-gal)的lacZ基因的逆轉(zhuǎn)錄病毒載體LXSN穩(wěn)定轉(zhuǎn)染CT26.WT細胞,得到致死的亞克隆CT26.CL25。即使CT26.CL25細胞表達了典型的TAA-β-半乳糖苷酶,在正常小鼠中CT26.CL25細胞和CT26.WT細胞的生長率與致死率也保持基本一致。CT26.WT細胞與CT26.CL25細胞一起可用作測試免疫治療程序的模型,并用于研究宿主免疫反應(yīng)。 |
年齡(性別) | 不詳 |
組織來源 | 器官:結(jié)腸;品系:BALB/c;疾?。喊?/td> |
細胞類型 | 腫瘤細胞 |
腫瘤類型 | 腸癌細胞 |
生物安全等級 | BSL-1 |
致瘤性 | Yes, in BALB/c mice. Mice inoculated, subcutaneously, developed lethal tumors at 80% frequency with 1×10^3 cells and at 100% with 1×10^4 cells. Pulmonary metastases developed when mice were inoculated, intravenously, with 1×10^4 cells. |
抗原表達情況 | H-2d |
保藏機構(gòu) | ATCC; CRL-2638 BCRC; 60447 |
STR鑒定
-
STR位點信息
18-3 19 6-7 12 5-5 14 X-1 25,26 1-2 17,18 7-1 25.2 8-1 13 1-1 14,15 19-2 13 15-3 21.3,22.3 12-1 16,17 6-4 18,20 4-2 21.3 3-2 14 2-1 16,17 13-1 16.2,17.2,18.2
11-2 17 17-2 15,16 -
STR鑒定圖
-
參考文獻
-
Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy (2025-01-11)
期刊:Nature Communications
DOI:10.1038/s41467-025-55905-y
影響因子 :14.7
引用產(chǎn)品: MCF7 [MCF-7] 細胞 , B16 細胞 , CT26.WT 細胞 , 4T1 細胞 , PANC-1 細胞
-
Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity (2025-01-16)
期刊:Cell Reports Medicine
DOI:10.1016/j.xcrm.2024.101913
影響因子 :11.7
引用產(chǎn)品: B16-F10 細胞 , 293T [HEK-293T] 細胞 , CT26.WT 細胞 , SW480 [SW-480] 細胞 , THP-1 細胞 , HCT 116 細胞 , TE-1 細胞
-
Titin gene mutations enhance radiotherapy efficacy via modulation of tumour immune microenvironment in rectum adenocarcinoma (2025-01-02)
期刊:Clinical and Translational Medicine
影響因子 :7.9
引用產(chǎn)品: CT26.WT 細胞 , CT26.WT細胞專用培養(yǎng)基
-
Hyaluronic acid-functionalized nanoparticles enable enhanced chemo/chemodynamic therapy for the targeted treatment of colon cancer (2025-02-01)
期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
DOI:10.1016/j.ijbiomac.2025.140553
影響因子 :7.7
引用產(chǎn)品: CT26.WT 細胞 , NRK-49F 細胞 , HL-1 細胞 , AML12 細胞
-
A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid exerts anti-tumor effects by C-type lectin pathway-mediated tumor associated macrophages repolarizing (2025-01-15)
期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
DOI:10.1016/j.ijbiomac.2025.139953
影響因子 :7.7
引用產(chǎn)品: CT26.WT 細胞 , MC38 細胞 , RAW 264.7 細胞
-
Plasma-activated saline hyperthermic perfusion-induced pyroptosis boosts peritoneal carcinomatosis immunotherapy (2025-02-04)
期刊:FREE RADICAL BIOLOGY AND MEDICINE
DOI:10.1016/j.freeradbiomed.2025.02.002
影響因子 :7.1
引用產(chǎn)品: CT26.WT 細胞 , MFC 細胞
-
Design, Synthesis, and Pharmacological Evaluation of Quinazoline and Quinoline Derivatives as Potent ENPP1 Inhibitors for Cancer Immunotherapy (2025-02-20)
期刊:JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1021/acs.jmedchem.4c03207
影響因子 :6.8
引用產(chǎn)品: CT26.WT 細胞
-
Liriope muscari baily saponin C induces apoptosis and autophagy in HCT116?cells via ROS generation (2025-02-04)
期刊:Food Bioscience
DOI:10.1016/j.fbio.2025.106073
影響因子 :4.8
引用產(chǎn)品: HCT 116 細胞 , CT26.WT 細胞
-
Effects of acteoside from Cistanche tubulosa on the plasma metabolome of cancer-related fatigue mice inoculated with colon cancer cells (2025-01-13)
期刊:Frontiers in Pharmacology
DOI:10.3389/fphar.2024.1370264
影響因子 :4.4
引用產(chǎn)品: CT26.WT 細胞
-
Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer (2024-09-13)
期刊:Molecular Cancer
DOI:10.1186/s12943-024-02108-6
影響因子 :27.7
引用產(chǎn)品: THP-1 細胞 , HCT 116 細胞 , CT26.WT 細胞 , 293T [HEK-293T] 細胞 , RAW 264.7 細胞
-
An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria (2024-06-14)
期刊:Science Bulletin
DOI:10.1016/j.scib.2024.06.016
影響因子 :18.8
引用產(chǎn)品: CT26.WT 細胞 , DC2.4 細胞
-
A Multifunctional Biomimetic Nanoplatform for Dual Tumor Targeting-Assisted Multimodal Therapy of Colon Cancer (2024-09-19)
期刊:ACS Nano
影響因子 :15.8
引用產(chǎn)品: 293T [HEK-293T] 細胞 , EL4 細胞 , RAW 264.7 細胞 , CT26.WT 細胞
-
A Tumor Environment-Activated Photosensitized Biomimetic Nanoplatform for Precise Photodynamic Immunotherapy of Colon Cancer (2024-05-10)
期刊:Advanced Science
影響因子 :14.3
引用產(chǎn)品: CT26.WT 細胞 , 293T [HEK-293T] 細胞 , BEAS-2B 細胞 , RAW 264.7 細胞
-
Leveraging chemotherapy-induced PD-L1 upregulation to potentiate targeted PD-L1 degradation using nanoparticle-based targeting chimeras (2024-09-18)
期刊:CHEMICAL ENGINEERING JOURNAL
影響因子 :13.3
引用產(chǎn)品: 4T1 細胞 , CT26.WT 細胞
-
Lysosome-Targeting Bacterial Outer Membrane Vesicles for Tumor Specific Degradation of PD-L1 (2024-06-27)
期刊:Small
影響因子 :13.0
引用產(chǎn)品: CT26.WT 細胞
-
Multivalent supramolecular fluorescent probes for accurate disease imaging (2024-10-18)
期刊:Science Advances
影響因子 :11.7
引用產(chǎn)品: RAW 264.7 細胞 , LX-2 細胞 , CT26.WT 細胞 , HK-2 細胞 , AML12 細胞
-
Full-active pharmaceutical ingredient nanosensitizer for augmented photoimmunotherapy by synergistic mitochondria targeting and immunogenic death inducing (2024-11-09)
期刊:MedComm
DOI:10.1002/mco2.756
影響因子 :10.7
引用產(chǎn)品: CT26.WT 細胞 , AGS 細胞
-
Targeted Clearance of Senescent Cells Via Engineered Extracellular Vesicles Reprograms Tumor Immunosuppressive Microenvironment (2024-05-24)
期刊:Advanced Healthcare Materials
影響因子 :10.0
引用產(chǎn)品: CT26.WT 細胞 , 293T [HEK-293T] 細胞
-
Prussian Blue-Derived Nanocomposite Synergized with Calcium Overload for Three-Mode ROS Outbreak Generation to Enhance Oncotherapy (2024-06-11)
期刊:Advanced Healthcare Materials
影響因子 :10.0
引用產(chǎn)品: CT26.WT 細胞
-
Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer (2024-01-20)
期刊:npj Biofilms and Microbiomes
DOI:10.1038/s41522-024-00479-8
影響因子 :9.2
引用產(chǎn)品: CT26.WT 細胞 , RKO 細胞 , SW480 [SW-480] 細胞
-
CXCL1/IGHG1 signaling enhances crosstalk between tumor cells and tumor-associated macrophages to promote MC-LR-induced colorectal cancer progression (2024-04-30)
期刊:ENVIRONMENTAL POLLUTION
DOI:10.1016/j.envpol.2024.124081
影響因子 :8.9
引用產(chǎn)品: RAW 264.7 細胞 , CT26.WT 細胞
-
Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis (2024-05-27)
期刊:Cell Communication and Signaling
DOI:10.1186/s12964-024-01669-9
影響因子 :8.4
引用產(chǎn)品: CT26.WT 細胞
-
Self-Assembled PEGylated Nanocubes Based on Hydrophobic Camptothecin and Doxorubicin for Combinational Therapy of Colorectal Cancer (2024-09-25)
期刊:ACS Applied Materials & Interfaces
影響因子 :8.3
引用產(chǎn)品: CT26.WT 細胞
-
Reshaped Local and Systemic Immune Responses Triggered by a Biomimetic Multifunctional Nanoplatform Coordinating Multi-Pathways for Cancer Therapy (2024-10-02)
期刊:ACS Applied Materials & Interfaces
影響因子 :8.3
引用產(chǎn)品: RAW 264.7 細胞 , CT26.WT 細胞
-
INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling (2024-09-02)
期刊:ACTA PHARMACOLOGICA SINICA
DOI:10.1038/s41401-024-01381-x
影響因子 :6.9
引用產(chǎn)品: 293T [HEK-293T] 細胞 , B16 細胞 , MC38 細胞 , CT26.WT 細胞 , 4T1 細胞
-
Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment (2024-06-14)
期刊:BIOMEDICINE & PHARMACOTHERAPY
DOI:10.1016/j.biopha.2024.116883
影響因子 :6.9
引用產(chǎn)品: CT26.WT 細胞 , SW620 細胞 , 特級胎牛血清
-
DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening (2024-11-07)
期刊:npj Precision Oncology
DOI:10.1038/s41698-024-00743-2
影響因子 :6.8
引用產(chǎn)品: HT-29 細胞 , CT26.WT 細胞 , DLD-1 細胞 , HCT 116 細胞
-
Ultrasound -Induced Thermal Effect Enhances the Efficacy of Chemotherapy and Immunotherapy in Tumor Treatment (2024-07-03)
期刊:International Journal of Nanomedicine
影響因子 :6.6
引用產(chǎn)品: CT26.WT 細胞
-
The Impact of Atmospheric Cadmium Exposure on Colon Cancer and the Invasiveness of Intestinal Stents in the Cancerous Colon (2024-03-14)
期刊:Toxics
影響因子 :4.6
引用產(chǎn)品: CT26.WT 細胞 , CT26.WT細胞專用培養(yǎng)基
-
Glycyrrhizin ameliorates colorectal cancer progression by regulating NHEJ pathway through inhibiting HMGB1-induced DNA damage response (2024-10-23)
期刊:Scientific Reports
DOI:10.1038/s41598-024-76155-w
影響因子 :3.8
引用產(chǎn)品: CT26.WT 細胞 , HCT 116 細胞 , HT-29 細胞
-
Berberine attenuates 5-fluorouracil-induced intestinal mucosal injury by modulating the gut microbiota without compromising its anti-tumor efficacy (2024-07-13)
期刊:Heliyon
DOI:10.1016/j.heliyon.2024.e34528
影響因子 :3.4
引用產(chǎn)品: CT26.WT 細胞
-
Astaxanthin Ameliorates Skeletal Muscle Atrophy in Mice With Cancer Cachexia (2024-04-03)
期刊:NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
DOI:10.1080/01635581.2024.2335584
影響因子 :2.9
引用產(chǎn)品: CT26.WT 細胞
-
Piperine induces autophagy of colon cancer cells: Dual modulation of AKT/mTOR signaling pathway and ROS production (2024-07-02)
期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI:10.1016/j.bbrc.2024.150340
影響因子 :2.5
引用產(chǎn)品: HCT 116 細胞 , SW480 [SW-480] 細胞 , SW620 細胞 , DLD-1 細胞 , CT26.WT 細胞 , NCM460 細胞 , IEC-6 細胞
-
Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy (2023-09-11)
期刊:Nature Nanotechnology
DOI:10.1038/s41565-023-01501-4
影響因子 :38.3
引用產(chǎn)品: 4T1 細胞 , EMT6 [EMT-6] 細胞 , Renca [RenCa] 細胞 , LLC [LL/2; LLC1] 細胞 , CT26.WT 細胞 , MFC 細胞
-
Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases (2023-06-14)
期刊:Molecular Cancer
DOI:10.1186/s12943-023-01790-2
影響因子 :37.3
引用產(chǎn)品: MGC80-3 [MGC-803] 細胞 , HGC-27 細胞 , CT26.WT 細胞 , CT26.WT 細胞
-
Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation (2023-07-26)
期刊:Nature Communications
DOI:10.1038/s41467-023-40207-y
影響因子 :16.6
引用產(chǎn)品: 4T1 細胞 , CT26.WT 細胞 , LLC [LL/2; LLC1] 細胞
-
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy (2023-05-24)
期刊:Advanced Science
影響因子 :15.1
引用產(chǎn)品: 4T1 細胞 , CT26.WT 細胞
-
Monocarboxylate transporter blockage-enabled lactate redistribution reshapes immunosuppressive tumor microenvironment and enhances chemodynamic immunotherapy (2023-11-07)
期刊:CHEMICAL ENGINEERING JOURNAL
影響因子 :15.1
引用產(chǎn)品: CT26.WT 細胞 , DC2.4 細胞
-
Microbubbles-assisted ultrasonication to promote tumor accumulation of therapeutics and modulation of tumor microenvironment for enhanced cancer treatments (2023-06-01)
期刊:BIOMATERIALS
DOI:10.1016/j.biomaterials.2023.122181
影響因子 :14.0
引用產(chǎn)品: CT26.WT 細胞 , 人臍靜脈內(nèi)皮細胞 , RPMI-1640 培養(yǎng)基
-
Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment (2023-02-09)
期刊:Biomaterials Research
DOI:10.1186/s40824-023-00350-5
影響因子 :11.3
引用產(chǎn)品: RAW 264.7 細胞 , CT26.WT 細胞
-
Original research: Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer (2023-08-18)
期刊:Journal for ImmunoTherapy of Cancer
影響因子 :10.9
引用產(chǎn)品: CT26.WT 細胞
-
Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner (2023-02-03)
期刊:Cancer Immunology Research
DOI:10.1158/2326-6066.CIR-22-0439
影響因子 :10.1
引用產(chǎn)品: Jurkat, Clone E6-1 細胞 , RKO 細胞 , CT26.WT 細胞 , B16-F10 細胞 , MC38 細胞 , 4T1 細胞 , LLC [LL/2; LLC1] 細胞 , Hepa 1-6 細胞 , YAC-1 細胞 , 293T [HEK-293T] 細胞 , AAV-293 細胞 , STR鑒定
-
Combination anti-PD-1 and electroacupuncture induces a potent anti-tumor immune response in microsatellite-stable colorectal cancer (2023-11-13)
期刊:Cancer Immunology Research
DOI:10.1158/2326-6066.CIR-23-0309
影響因子 :10.1
引用產(chǎn)品: CT26.WT 細胞
-
Dynamic shielding of bacterial outer membrane vesicles for safe and efficient chemo-immunotherapy against tumors (2023-11-17)
期刊:Nano Research
影響因子 :9.9
引用產(chǎn)品: CT26.WT 細胞
-
Aggregation-induced emission photosensitizer/bacteria biohybrids enhance Cerenkov radiation-induced photodynamic therapy by activating anti-tumor immunity for synergistic tumor treatment (2023-06-15)
期刊:Acta Biomaterialia
DOI:10.1016/j.actbio.2023.06.009
影響因子 :9.7
引用產(chǎn)品: CT26.WT 細胞
-
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy (2023-11-08)
期刊:Cell Chemical Biology
DOI:10.1016/j.chembiol.2023.10.010
影響因子 :8.6
引用產(chǎn)品: EMT6 [EMT-6] 細胞 , MC38 細胞 , B16 細胞 , CT26.WT 細胞
-
Smart Nanosystem-Mediated Inhibition of Mitochondrial Respiration for Enhanced Phototherapy-Induced Antitumor Immunity (2023-06-25)
期刊:International Journal of Nanomedicine
影響因子 :8.0
引用產(chǎn)品: CT26.WT 細胞 , RPMI-1640 培養(yǎng)基 , 特級胎牛血清
-
Dual-inhibition of lactate metabolism and Prussian blue-mediated radical generation for enhanced chemodynamic therapy and antimetastatic effect (2023-04-18)
期刊:Nanoscale
影響因子 :6.7
引用產(chǎn)品: RPMI-1640完全培養(yǎng)基 (含10%FBS) , NCTC clone 929 [L 細胞, L-929] 細胞 , CT26.WT 細胞
-
Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice (2023-04-24)
期刊:LIFE SCIENCES
影響因子 :6.1
引用產(chǎn)品: CT26.WT 細胞
-
Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model (2023-12-14)
期刊:Frontiers in Pharmacology
DOI:10.3389/fphar.2023.1286061
影響因子 :5.6
引用產(chǎn)品: CT26.WT 細胞 , MCA38 細胞 , 4T1 細胞 , 特級胎牛血清
-
TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells (2023-11-15)
期刊:American Journal of Cancer Research
DOI:PMID:38058799
影響因子 :5.3
引用產(chǎn)品: RPMI-1640 培養(yǎng)基 , CT26.WT 細胞 , 特級胎牛血清
-
Excessive consumption of mucin by over-colonized Akkermansia muciniphila promotes intestinal barrier damage during malignant intestinal environment (2023-03-02)
期刊:Frontiers in Microbiology
DOI:10.3389/fmicb.2023.1111911
影響因子 :5.2
引用產(chǎn)品: CT26.WT 細胞
-
Ferulic Acid Induces Autophagy and Apoptosis in Colon Cancer CT26 Cells via the MAPK Pathway (2023-08-11)
期刊:MOLECULES
影響因子 :4.6
引用產(chǎn)品: CT26.WT 細胞
-
Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway (2023-12-27)
期刊:Pharmaceuticals
影響因子 :4.6
引用產(chǎn)品: HCT 116 細胞 , SW480 [SW-480] 細胞 , CT26.WT 細胞
-
Self-Assembled Amphiphilic Camptothecin Nanoparticles with Glutathione-Responsive and Tumor-Targeting Ability for Enhanced Colorectal Cancer Therapy (2023-09-21)
期刊:Advanced Therapeutics
影響因子 :4.6
引用產(chǎn)品: CT26.WT 細胞
-
Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression (2023-03-22)
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2023.113565
影響因子 :3.7
引用產(chǎn)品: CT26.WT 細胞
-
MiR-26a-5p exerts its influence by targeting EP300, a molecule known for its role in activating the PI3K/AKT/mTOR signaling pathway in CD8+tumor-infiltrating lymphocytes of colorectal cancer (2023-11-30)
期刊:CELLULAR AND MOLECULAR BIOLOGY
DOI:10.14715/cmb/2023.69.12.37
影響因子 :1.6
引用產(chǎn)品: CT26.WT 細胞
-
Synthetic Lignin-Derived Therapeutic Nano Reagent as Intestinal pH-Sensitive Drug Carriers Capable of Bypassing the Gastric Acid Environment for Colitis Treatment (2022-12-15)
期刊:ACS Nano
影響因子 :18.0
引用產(chǎn)品: RAW 264.7 細胞 , CT26.WT 細胞 , 人臍靜脈內(nèi)皮細胞
-
Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments (2022-11-09)
期刊:Science Advances
影響因子 :15.0
引用產(chǎn)品: Hela 細胞 , HT-29 細胞 , HCT 116 細胞 , CT26.WT 細胞 , DMEM高糖 培養(yǎng)基 , McCoy's 5A 培養(yǎng)基 , RPMI-1640 培養(yǎng)基
-
A hybrid of lactic acid bacteria and metal-organic frameworks potentiates photodynamic immunotherapy for hypoxia-targeted tumor eradication (2022-08-12)
期刊:Science China-Materials
影響因子 :8.6
引用產(chǎn)品: CT26.WT 細胞 , RAW 264.7 細胞
-
CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B (2022-09-14)
期刊:Cells
影響因子 :7.7
引用產(chǎn)品: U-87 MG 細胞 , A549 [A-549] 細胞 , F9 細胞 , CT26.WT 細胞
-
Arrangement of Indocyanine Green in a 1.5-Nanometer Channel to Achieve High-Efficiency Imaging of the Intestinal Lymphatic System (2022-12-08)
期刊:MOLECULES
影響因子 :4.9
引用產(chǎn)品: 小鼠淋巴管內(nèi)皮細胞 , RAW 264.7 細胞 , CT26.WT 細胞
-
A serum metabolomics study based on LC-MS: Chemosensitization effects of Rauvolfia vomitoria Afzel. combined with 5- fluorouracil on colorectal cancer mice (2022-09-22)
期刊:JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
DOI:10.1016/j.jpba.2022.115074
影響因子 :3.6
引用產(chǎn)品: CT26.WT 細胞
-
Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer (2022-10-07)
期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI:10.1016/j.bbrc.2022.10.027
影響因子 :3.3
引用產(chǎn)品: CT26.WT 細胞
-
GSH-Responsive Dnase-I-Loaded MnOx Nanoplatforms for Combined Protein-Chemodynamic Therapy (2022-12-29)
期刊:Advanced NanoBiomed Research
影響因子 :
引用產(chǎn)品: CT26.WT 細胞 , HSF 細胞
-
Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation (2021-02-24)
期刊:Drug Design Development and Therapy
影響因子 :4.3
引用產(chǎn)品: CT26.WT 細胞
-
Lycorine Induces autophagy-associated apoptosis by targeting MEK2 and enhances vemurafenib activity in colorectal cancer (2020-01-03)
期刊:Aging-US
影響因子 :5.2
引用產(chǎn)品: HCT 116 細胞 , SW480 [SW-480] 細胞 , RKO 細胞 , CT26.WT 細胞
-
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway (2020-04-30)
期刊:Frontiers in Microbiology
影響因子 :5.2
引用產(chǎn)品: CT26.WT 細胞
-
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species (2019-08-15)
期刊:Biomaterials Science
影響因子 :6.6
引用產(chǎn)品: CT26.WT 細胞
-
A tungsten nitride-based degradable nanoplatform for dual-modal image-guided combinatorial chemo-photothermal therapy of tumors (2018-12-27)
期刊:Nanoscale
影響因子 :6.7
引用產(chǎn)品: CT26.WT 細胞 , 4T1 細胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識別碼示意圖